Aspirin
This article was originally published in The Tan Sheet
Executive Summary
High doses appear to inhibit immune cells in bone marrow related to autoimmune diseases, rejection of transplanted organs, suggesting new therapeutic use for analgesic, Holger Hackstein, MD, et al., University of Pittsburgh, report in Journal of Immunology June 15. Mouse study prompts researchers to plan follow-up research into organ transplant applications. Patients should not take high doses of aspirin after transplants based on current data, Hackstein et al. caution
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning